BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27174920)

  • 41. GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death.
    Alves-Silva JC; de Carvalho JL; Rabello DA; Serejo TRT; Rego EM; Neves FAR; Lucena-Araujo AR; Pittella-Silva F; Saldanha-Araujo F
    Invest New Drugs; 2018 Oct; 36(5):955-960. PubMed ID: 29855824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic Silencing of 15-Hydroxyprostaglandin Dehydrogenase by Histone Methyltransferase EHMT2/G9a in Cholangiocarcinoma.
    Zhang J; Chen W; Ma W; Song K; Lee S; Han C; Wu T
    Mol Cancer Res; 2022 Mar; 20(3):350-360. PubMed ID: 34880125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of G9a inhibitor BIX‑01294 acting on U251 glioma cells.
    Guo AS; Huang YQ; Ma XD; Lin RS
    Mol Med Rep; 2016 Nov; 14(5):4613-4621. PubMed ID: 27748874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel Function of Lysine Methyltransferase G9a in the Regulation of Sox2 Protein Stability.
    Lee JY; Lee SH; Heo SH; Kim KS; Kim C; Kim DK; Ko JJ; Park KS
    PLoS One; 2015; 10(10):e0141118. PubMed ID: 26492085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1.
    Duan Z; Zarebski A; Montoya-Durango D; Grimes HL; Horwitz M
    Mol Cell Biol; 2005 Dec; 25(23):10338-51. PubMed ID: 16287849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mTORC1-G9a-H3K9me2 axis negatively regulates autophagy in fatty acid-induced hepatocellular lipotoxicity.
    Mushtaq A; Ashraf NU; Altaf M
    J Biol Chem; 2023 Mar; 299(3):102937. PubMed ID: 36690274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification by high-throughput imaging of the histone methyltransferase EHMT2 as an epigenetic regulator of VEGFA alternative splicing.
    Salton M; Voss TC; Misteli T
    Nucleic Acids Res; 2014 Dec; 42(22):13662-73. PubMed ID: 25414343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The selective activation of p53 target genes regulated by SMYD2 in BIX-01294 induced autophagy-related cell death.
    Fan JD; Lei PJ; Zheng JY; Wang X; Li S; Liu H; He YL; Wang ZN; Wei G; Zhang X; Li LY; Wu M
    PLoS One; 2015; 10(1):e0116782. PubMed ID: 25562686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancer.
    Thng DKH; Hooi L; Toh CCM; Lim JJ; Rajagopalan D; Syariff IQC; Tan ZM; Rashid MBMA; Zhou L; Kow AWC; Bonney GK; Goh BKP; Kam JH; Jha S; Dan YY; Chow PKH; Toh TB; Chow EK
    Mol Oncol; 2023 Nov; 17(11):2275-2294. PubMed ID: 36896891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LncRNA TRERNA1 facilitates hepatocellular carcinoma metastasis by dimethylating H3K9 in the CDH1 promoter region via the recruitment of the EHMT2/SNAI1 complex.
    Song W; Gu Y; Lu S; Wu H; Cheng Z; Hu J; Qian Y; Zheng Y; Fan H
    Cell Prolif; 2019 Jul; 52(4):e12621. PubMed ID: 31012192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Properly substituted analogues of BIX-01294 lose inhibition of G9a histone methyltransferase and gain selective anti-DNA methyltransferase 3A activity.
    Rotili D; Tarantino D; Marrocco B; Gros C; Masson V; Poughon V; Ausseil F; Chang Y; Labella D; Cosconati S; Di Maro S; Novellino E; Schnekenburger M; Grandjenette C; Bouvy C; Diederich M; Cheng X; Arimondo PB; Mai A
    PLoS One; 2014; 9(5):e96941. PubMed ID: 24810902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lysine methyltransferase G9a is an important modulator of trained immunity.
    Mourits VP; van Puffelen JH; Novakovic B; Bruno M; Ferreira AV; Arts RJ; Groh L; Crișan TO; Zwaag J; Jentho E; Kox M; Pickkers P; van de Veerdonk FL; Weis S; Oosterwijk E; Vermeulen SH; Netea MG; Joosten LA
    Clin Transl Immunology; 2021; 10(2):e1253. PubMed ID: 33708384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physalin A induces apoptosis via p53-Noxa-mediated ROS generation, and autophagy plays a protective role against apoptosis through p38-NF-κB survival pathway in A375-S2 cells.
    He H; Zang LH; Feng YS; Chen LX; Kang N; Tashiro S; Onodera S; Qiu F; Ikejima T
    J Ethnopharmacol; 2013 Jul; 148(2):544-55. PubMed ID: 23684722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone Methyltransferase G9a Is Required for Cardiomyocyte Homeostasis and Hypertrophy.
    Papait R; Serio S; Pagiatakis C; Rusconi F; Carullo P; Mazzola M; Salvarani N; Miragoli M; Condorelli G
    Circulation; 2017 Sep; 136(13):1233-1246. PubMed ID: 28778944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human EHMT2/G9a activates p53 through methylation-independent mechanism.
    Rada M; Vasileva E; Lezina L; Marouco D; Antonov AV; Macip S; Melino G; Barlev NA
    Oncogene; 2017 Feb; 36(7):922-932. PubMed ID: 27452519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
    Renneville A; Van Galen P; Canver MC; McConkey M; Krill-Burger JM; Dorfman DM; Holson EB; Bernstein BE; Orkin SH; Bauer DE; Ebert BL
    Blood; 2015 Oct; 126(16):1930-9. PubMed ID: 26320100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway.
    Wang L; Dong X; Ren Y; Luo J; Liu P; Su D; Yang X
    Cell Death Dis; 2018 Jan; 9(2):129. PubMed ID: 29374157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Euchromatic histone methyltransferase 2 inhibitor, BIX-01294, sensitizes human promyelocytic leukemia HL-60 and NB4 cells to growth inhibition and differentiation.
    Savickiene J; Treigyte G; Stirblyte I; Valiuliene G; Navakauskiene R
    Leuk Res; 2014 Jul; 38(7):822-9. PubMed ID: 24832370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BIX-01294 increases pig cloning efficiency by improving epigenetic reprogramming of somatic cell nuclei.
    Huang J; Zhang H; Yao J; Qin G; Wang F; Wang X; Luo A; Zheng Q; Cao C; Zhao J
    Reproduction; 2016 Jan; 151(1):39-49. PubMed ID: 26604326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.